{"id":"https://openalex.org/W2078025075","doi":"https://doi.org/10.1111/j.1399-5618.2010.00789.x","title":"Impact of obsessive\u2010compulsive disorder on the antimanic response to olanzapine therapy in youth with bipolar disorder","display_name":"Impact of obsessive\u2010compulsive disorder on the antimanic response to olanzapine therapy in youth with bipolar disorder","publication_year":2010,"publication_date":"2010-03-01","ids":{"openalex":"https://openalex.org/W2078025075","doi":"https://doi.org/10.1111/j.1399-5618.2010.00789.x","mag":"2078025075","pmid":"https://pubmed.ncbi.nlm.nih.gov/20402712"},"language":"en","primary_location":{"id":"doi:10.1111/j.1399-5618.2010.00789.x","doi":"https://doi.org/10.1111/j.1399-5618.2010.00789.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1399-5618.2010.00789.x","pdf_url":null,"source":{"id":"https://openalex.org/S58085280","display_name":"Bipolar Disorders","issn_l":"1398-5647","issn":["1398-5647","1399-5618"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bipolar Disorders","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087895260","display_name":"Gagan Joshi","orcid":"https://orcid.org/0000-0002-6628-2835","observed_orcids":["https://orcid.org/0000-0002-6628-2835"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Gagan Joshi","raw_affiliation_strings":["Pediatric Psychopharmacology Research Program, Massachusetts General Hospital, Boston, MA 02114, USA. joshi.gagan@mgh.harvard.edu","Department of Psychiatry, Harvard Medical School, Cambridge, MA, USA","Pediatric Psychopharmacology Research Program, Massachusetts General Hospital, Boston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Psychopharmacology Research Program, Massachusetts General Hospital, Boston, MA 02114, USA. joshi.gagan@mgh.harvard.edu","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Department of Psychiatry, Harvard Medical School, Cambridge, MA, USA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Pediatric Psychopharmacology Research Program, Massachusetts General Hospital, Boston","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071835676","display_name":"Eric O. Mick","orcid":"https://orcid.org/0000-0001-8505-8145","observed_orcids":["https://orcid.org/0000-0001-8505-8145"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Mick","raw_affiliation_strings":["Department of Psychiatry, Harvard Medical School, Cambridge, MA, USA","Pediatric Psychopharmacology Research Program, Massachusetts General Hospital, Boston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Harvard Medical School, Cambridge, MA, USA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Pediatric Psychopharmacology Research Program, Massachusetts General Hospital, Boston","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077744833","display_name":"Janet R. Wozniak","orcid":"https://orcid.org/0000-0002-1250-886X","observed_orcids":["https://orcid.org/0000-0002-1250-886X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janet Wozniak","raw_affiliation_strings":["Department of Psychiatry, Harvard Medical School, Cambridge, MA, USA","Pediatric Psychopharmacology Research Program, Massachusetts General Hospital, Boston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Harvard Medical School, Cambridge, MA, USA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Pediatric Psychopharmacology Research Program, Massachusetts General Hospital, Boston","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100418099","display_name":"DANIEL A. GELLER","orcid":"https://orcid.org/0000-0001-8692-4156","observed_orcids":["https://orcid.org/0000-0001-8692-4156"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Geller","raw_affiliation_strings":["Department of Psychiatry, Harvard Medical School, Cambridge, MA, USA","Pediatric Psychopharmacology Research Program, Massachusetts General Hospital, Boston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Harvard Medical School, Cambridge, MA, USA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Pediatric Psychopharmacology Research Program, Massachusetts General Hospital, Boston","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031218409","display_name":"Jennifer M. Park","orcid":"https://orcid.org/0000-0001-9602-475X","observed_orcids":["https://orcid.org/0000-0001-9602-475X"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Park","raw_affiliation_strings":["Pediatric Psychopharmacology Research Program, Massachusetts General Hospital, Boston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Psychopharmacology Research Program, Massachusetts General Hospital, Boston","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023002822","display_name":"Samara Strauss","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samara Strauss","raw_affiliation_strings":["Pediatric Psychopharmacology Research Program, Massachusetts General Hospital, Boston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Psychopharmacology Research Program, Massachusetts General Hospital, Boston","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070269405","display_name":"Joseph Biederman","orcid":"https://orcid.org/0000-0001-8233-663X","observed_orcids":["https://orcid.org/0000-0001-8233-663X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Biederman","raw_affiliation_strings":["Department of Psychiatry, Harvard Medical School, Cambridge, MA, USA","Pediatric Psychopharmacology Research Program, Massachusetts General Hospital, Boston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Harvard Medical School, Cambridge, MA, USA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Pediatric Psychopharmacology Research Program, Massachusetts General Hospital, Boston","institution_ids":["https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5087895260"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"],"apc_list":{"value":4730,"currency":"USD","value_usd":4730},"apc_paid":null,"fwci":2.5032,"has_fulltext":false,"cited_by_count":31,"citation_normalized_percentile":{"value":0.88244954,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"12","issue":"2","first_page":"196","last_page":"204"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11093","display_name":"Personality Disorders and Psychopathology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/obsessive-compulsive-disorder","display_name":"obsessive-compulsive disorder","score":0.9129999876022339},{"id":"https://openalex.org/keywords/bipolar-disorder","display_name":"bipolar disorder","score":0.9330000281333923},{"id":"https://openalex.org/keywords/youth","display_name":"youth","score":0.8379999995231628},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":0.9879999756813049},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.8270000219345093},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8339999914169312},{"id":"https://openalex.org/keywords/mania","display_name":"mania","score":0.7570000290870667},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.546999990940094},{"id":"https://openalex.org/keywords/young-mania-rating-scale","display_name":"Young Mania Rating Scale","score":0.8040000200271606}],"concepts":[{"id":"https://openalex.org/C2777089681","wikidata":"https://www.wikidata.org/wiki/Q4340609","display_name":"Young Mania Rating Scale","level":5,"score":0.8705848455429077},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.827664315700531},{"id":"https://openalex.org/C2776809841","wikidata":"https://www.wikidata.org/wiki/Q185935","display_name":"Mania","level":4,"score":0.7631938457489014},{"id":"https://openalex.org/C2776174506","wikidata":"https://www.wikidata.org/wiki/Q131755","display_name":"Bipolar disorder","level":3,"score":0.7125236988067627},{"id":"https://openalex.org/C2779159551","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Comorbidity","level":2,"score":0.7080866098403931},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5628465414047241},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47463616728782654},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.46496492624282837},{"id":"https://openalex.org/C2778609679","wikidata":"https://www.wikidata.org/wiki/Q4915474","display_name":"Bipolar I disorder","level":5,"score":0.46210891008377075},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.38202595710754395},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32199570536613464},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.19624552130699158},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.15245160460472107}],"mesh":[{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009771","descriptor_name":"Obsessive-Compulsive Disorder","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D009771","descriptor_name":"Obsessive-Compulsive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009771","descriptor_name":"Obsessive-Compulsive Disorder","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015897","descriptor_name":"Comorbidity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018692","descriptor_name":"Antimanic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1399-5618.2010.00789.x","doi":"https://doi.org/10.1111/j.1399-5618.2010.00789.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1399-5618.2010.00789.x","pdf_url":null,"source":{"id":"https://openalex.org/S58085280","display_name":"Bipolar Disorders","issn_l":"1398-5647","issn":["1398-5647","1399-5618"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bipolar Disorders","raw_type":"journal-article"},{"id":"pmid:20402712","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20402712","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bipolar disorders","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1606930128","https://openalex.org/W1623346414","https://openalex.org/W1971114910","https://openalex.org/W1999689270","https://openalex.org/W1999783912","https://openalex.org/W2015526673","https://openalex.org/W2016437353","https://openalex.org/W2020465915","https://openalex.org/W2022523822","https://openalex.org/W2041747179","https://openalex.org/W2042651995","https://openalex.org/W2059256690","https://openalex.org/W2065640011","https://openalex.org/W2068326708","https://openalex.org/W2072097658","https://openalex.org/W2088971050","https://openalex.org/W2089448534","https://openalex.org/W2090199551","https://openalex.org/W2092599709","https://openalex.org/W2093449642","https://openalex.org/W2117158126","https://openalex.org/W2124776289","https://openalex.org/W2127608265","https://openalex.org/W2163049696","https://openalex.org/W2165379748","https://openalex.org/W2167659819","https://openalex.org/W2411351778","https://openalex.org/W4297888599","https://openalex.org/W4323284061"],"related_works":["https://openalex.org/W4243445934","https://openalex.org/W1982799203","https://openalex.org/W1982911320","https://openalex.org/W1999443587","https://openalex.org/W2116393028","https://openalex.org/W4229057626","https://openalex.org/W2909523825","https://openalex.org/W2793664598","https://openalex.org/W2184512697","https://openalex.org/W4387651889"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"compare":[2],"antimanic":[3,169,197],"response":[4,90,170],"to":[5,171],"olanzapine":[6,34,72,172],"therapy":[7,35,173],"in":[8,36,70,91,97,143,157,174,199],"youth":[9,37,200],"with":[10,20,38,44,160,179,201],"bipolar":[11],"disorder":[12,22],"(BPD)":[13],"based":[14],"on":[15],"the":[16,45,59,71,98,144,175,194],"status":[17],"of":[18,27,33,41,100,146,177,196,210,213,217],"comorbidity":[19,178,190],"obsessive-compulsive":[21],"(OCD).":[23],"METHODS:":[24],"Secondary":[25],"analysis":[26,212],"identically":[28],"designed":[29],"8-week":[30],"open-label":[31],"trials":[32,73,216,224],"BPD.":[39,202],"Severity":[40],"mania":[42],"assessed":[43],"Young":[46],"Mania":[47],"Rating":[48],"Scale":[49],"(YMRS)":[50],"and":[51],"Clinical":[52],"Global":[53],"Impression":[54],"(CGI)":[55],"scales.":[56],"RESULTS:":[57],"Of":[58],"52":[60],"BPD":[61,92,158],"subjects":[62,93,159],"(mean":[63,74],"age":[64],"8.4":[65],"+/-":[66,77,107,111],"3.1":[67],"years)":[68],"enrolled":[69],"dose":[75],"8.5":[76],"4.3":[78],"mg/day),":[79],"39%":[80],"(n":[81],"=":[82,114,118,125,131,137,152],"20)":[83],"met":[84],"criteria":[85],"for":[86],"comorbid":[87,101,163],"OCD.":[88,164],"Antimanic":[89],"was":[94,140],"significantly":[95],"worse":[96],"presence":[99,176],"OCD":[102,180,183],"(YMRS":[103],"mean":[104],"reduction:":[105,120],"-5.9":[106],"13.1":[108],"versus":[109,122,134,149],"-13.7":[110],"18.8,":[112],"p":[113,124,136,151],"0.04;":[115],">":[116],"or":[117,130,154,161],"30%":[119],"25%":[121,133],"63%,":[123],"0.008;":[126],"CGI-Improvement":[127],"score":[128],"<":[129],"2:":[132],"68%,":[135],"0.003).":[138],"There":[139],"no":[141],"difference":[142],"rate":[145],"dropouts":[147],"(50%":[148],"29%,":[150],"0.2)":[153],"adverse":[155],"effects":[156],"without":[162],"CONCLUSIONS:":[165],"Less":[166],"than":[167],"expected":[168],"suggests":[181],"that":[182,191],"is":[184,205],"an":[185,218],"important":[186],"functionally":[187],"impairing":[188],"psychiatric":[189],"may":[192],"impact":[193],"efficacy":[195],"agents":[198],"This":[203],"study":[204],"limited":[206],"by":[207],"its":[208],"design":[209],"secondary":[211],"data":[214],"from":[215],"uncontrolled":[219],"nature.":[220],"Further":[221],"prospective":[222],"controlled":[223],"are":[225],"warranted.":[226]},"counts_by_year":[{"year":2024,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":6},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}